Humana (NYSE:HUM – Get Free Report) was upgraded by stock analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, Marketbeat Ratings reports. Wolfe Research upgraded shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $331.09. Get Humana alerts:Get Our Latest Stock Analysis on HUMHumana Price PerformanceHUM stock traded down $26.12 during trading on Wednesday, reaching $362.59. In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.